Clinical studies with non-iressa EGFR tyrosine kinase inhibitors.
about
The role of airway secretions in COPD: pathophysiology, epidemiology and pharmacotherapeutic options.Induction of Na+/K+/2Cl- cotransporter expression mediates chronic potentiation of intestinal epithelial Cl- secretion by EGF.The tyrosine kinase inhibitor ZD6474 inhibits tumour growth in an intracerebral rat glioma model.Differential contribution to neuroendocrine tumorigenesis of parallel egfr signaling in cancer cells and pericytes
P2860
Clinical studies with non-iressa EGFR tyrosine kinase inhibitors.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Clinical studies with non-iressa EGFR tyrosine kinase inhibitors.
@ast
Clinical studies with non-iressa EGFR tyrosine kinase inhibitors.
@en
type
label
Clinical studies with non-iressa EGFR tyrosine kinase inhibitors.
@ast
Clinical studies with non-iressa EGFR tyrosine kinase inhibitors.
@en
prefLabel
Clinical studies with non-iressa EGFR tyrosine kinase inhibitors.
@ast
Clinical studies with non-iressa EGFR tyrosine kinase inhibitors.
@en
P1433
P1476
Clinical studies with non-iressa EGFR tyrosine kinase inhibitors.
@en
P2093
Philip Bonomi
P356
10.1016/S0169-5002(03)00141-7
P478
41 Suppl 1
P577
2003-08-01T00:00:00Z